[1]
|
中国特应性皮炎诊疗指南(2020版) [J]. 中华皮肤科杂志, 2020, 53(2): 81-88.
|
[2]
|
Grinberg-Bleyer, Y., Caron, R., Seeley, J.J, et al. (2018) The Alternative NF-kappaB Pathway in Regulatory T Cell Homeostasis and Suppressive Function. The Journal of Immunology, 200, 2362-2371.
https://doi.org/10.4049/jimmunol.1800042
|
[3]
|
Roesner, L.M., Floess, S., Witte, T., et al. (2015) Foxp3(+) Reg-ulatory T Cells Are Expanded in Severe Atopic Dermatitis Patients. Allergy, 70, 1656-1660. https://doi.org/10.1111/all.12712
|
[4]
|
Moosbrugger-Martinz, V., Tripp, C.H., Clausen, B.E, et al. (2016) Atopic Dermatitis Induces the Expansion of Thymus-Derived Regulatory T Cells Exhibiting a Th2-Like Phenotype in Mice. Journal of Cellular and Molecular Medicine, 20, 930-938. https://doi.org/10.1111/jcmm.12806
|
[5]
|
Agrawal, R., Wisniewski, J.A. and Woodfolk, J.A. (2011) The Role of Regulatory T Cells in Atopic Dermatitis. Current Problems in Dermatology, 41, 112-124. https://doi.org/10.1159/000323305
|
[6]
|
Keubler, L.M., Buettner, M., Hager, C., et al. (2015) A Multihit Model: Colitis Lessons from the Interleukin-10-Deficient Mouse. Inflammatory Bowel Diseases, 21, 1967-1975.
https://doi.org/10.1097/MIB.0000000000000468
|
[7]
|
Fyhrquist, N., Lehtimaki, S., Lahl, K., et al. (2012) Foxp3+ Cells Control Th2 Responses in a Murine Model of Atopic Dermatitis. Journal of Investigative Dermatology, 132, 1672-1680. https://doi.org/10.1038/jid.2012.40
|
[8]
|
Nie, J., Li, Y.Y., Zheng, S.G., et al. (2015) FOXP3(+) Treg Cells and Gender Bias in Autoimmune Diseases. Frontiers in Immunology, 6, Article No. 493. https://doi.org/10.3389/fimmu.2015.00493
|
[9]
|
Noval Rivas, M. and Chatila, T.A. (2016) Regulatory T Cells in Allergic Diseases. The Journal of Allergy and Clinical Immunology, 138, 639-652. https://doi.org/10.1016/j.jaci.2016.06.003
|
[10]
|
Shin, J.U., Kim, S.H., Noh, J.Y., et al. (2018) Allergen-Specific Immunotherapy Induces Regulatory T Cells in an Atopic Dermatitis Mouse Model. Allergy, 73, 1801-1811. https://doi.org/10.1111/all.13465
|
[11]
|
Malhotra, N., Leyva-Castillo, J.M., Jadhav, U., et al. (2018) RORalpha-Expressing T Regulatory Cells Restrain Allergic Skin Inflammation. Science Immunology, 3, eaao6923. https://doi.org/10.1126/sciimmunol.aao6923
|
[12]
|
Halabi-Tawil, M., Ruemmele, F.M., Fraitag, S., et al. (2009) Cutaneous Manifestations of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome. British Journal of Dermatology, 160, 645-651.
https://doi.org/10.1111/j.1365-2133.2008.08835.x
|
[13]
|
Gaspar, K., Barath, S., Nagy, G., et al. (2015) Regulatory T-Cell Subsets with Acquired Functional Impairment: Important Indicators of Disease Severity in Atopic Dermatitis. Acta Dermato-Venereologica, 95, 151-155.
https://doi.org/10.2340/00015555-1882
|
[14]
|
Zhang, Y.Y., Wang, A.X., Xu, L., et al. (2016) Characteristics of Peripheral Blood CD4+CD25+ Regulatory T Cells and Related Cytokines in Severe Atopic Dermatitis. European Journal of Dermatology, 26, 240-246.
https://doi.org/10.1684/ejd.2015.2709
|
[15]
|
Hinz, D., Bauer, M., Roder, S., et al. (2012) Cord Blood Tregs with Stable FOXP3 Expression Are Influenced by Prenatal Environment and Associated with Atopic Dermatitis at the Age of One Year. Allergy, 67, 380-389.
https://doi.org/10.1111/j.1398-9995.2011.02767.x
|
[16]
|
Schaub, B., Liu, J., Hoppler, S., et al. (2008) Impairment of T-Regulatory Cells in Cord Blood of Atopic Mothers. The Journal of Allergy and Clinical Immunology, 121, 1491-1499, 1499.e1-13. https://doi.org/10.1016/j.jaci.2008.04.010
|
[17]
|
Kim, H.J., Kim, Y.J., Lee, S.H., et al. (2014) Effects of Lactobacillus rhamnosus on Allergic March Model by Suppressing Th2, Th17, and TSLP Responses via CD4(+)CD25(+)Foxp3(+) Tregs. Clinical Immunology, 153, 178-186.
https://doi.org/10.1016/j.clim.2014.04.008
|
[18]
|
Lin, Y.T., Wang, C.T., Chao, P.S., et al. (2011) Skin-Homing CD4+ Foxp3+ T Cells Exert Th2-Like Function after Staphylococcal Superantigen Stimulation in Atopic Dermatitis Patients. Clinical & Experimental Allergy, 41, 516-525.
https://doi.org/10.1111/j.1365-2222.2010.03681.x
|
[19]
|
Mittag, D., Scholzen, A., Varese, N., et al. (2010) The Effector T Cell Response to Ryegrass Pollen Is Counter Regulated by Simultaneous Induction of Regulatory T Cells. The Journal of Immunology, 184, 4708-4716.
https://doi.org/10.4049/jimmunol.0901036
|
[20]
|
Mobs, C., Slotosch, C., Loffler, H., et al. (2010) Birch Pollen Immunotherapy Leads to Differential Induction of Regulatory T Cells and Delayed Helper T Cell Immune Deviation. The Journal of Immunology, 184, 2194-2203.
https://doi.org/10.4049/jimmunol.0901379
|
[21]
|
Thunberg, S., Akdis, M., Akdis, C.A., et al. (2007) Immune Regulation by CD4+CD25+ T Cells and Interleukin-10 in Birch Pollen-Allergic Patients and Non-Allergic Controls. Clinical & Experimental Allergy, 37, 1127-1136.
https://doi.org/10.1111/j.1365-2222.2007.02739.x
|
[22]
|
Kuhn, C. and Weiner, H.L. (2016) Therapeutic Anti-CD3 Monoclonal Antibodies from Bench to Bedside. Immunotherapy, 8, 889-906. https://doi.org/10.2217/imt-2016-0049
|
[23]
|
Spence, A., Klementowicz, J.E., Bluestone, J.A., et al. (2015) Tar-geting Treg Signaling for the Treatment of Autoimmune Diseases. Current Opinion in Immunology, 37, 11-20. https://doi.org/10.1016/j.coi.2015.09.002
|
[24]
|
Powell, J.D. and Delgoffe, G.M. (2010) The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and Metabolism. Immunity, 33, 301-311. https://doi.org/10.1016/j.immuni.2010.09.002
|
[25]
|
Charbonnier, L.M., Cui, Y., Stephen-Victor, E., et al. (2019) Functional Reprogramming of Regulatory T Cells in the Absence of Foxp3. Nature Immunology, 20, 1208-1219. https://doi.org/10.1038/s41590-019-0442-x
|
[26]
|
Son, S.E., Park, S.J., Koh, J.M., et al. (2020) Free Fatty Acid Receptor 4 (FFA4) Activation Ameliorates 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis by Increasing Regu-latory T Cells in Mice. Acta Pharmacologica Sinica, 41, 1337-1347. https://doi.org/10.1038/s41401-020-0435-1
|
[27]
|
Nasri, H. and Rafieian-Kopaei, M. (2014) Metformin: Current Knowledge. Journal of Research in Medical Sciences, 19, 658-664.
|
[28]
|
Fischer, K.E., Gelfond, J.A., Soto, V.Y., et al. (2015) Health Effects of Long-Term Rapamycin Treatment: The Impact on Mouse Health of Enteric Rapamycin Treatment from Four Months of Age throughout Life. PLoS ONE, 10, e0126644. https://doi.org/10.1371/journal.pone.0126644
|
[29]
|
Danikowski, K.M., Jayaraman, S. and Prabhakar, B.S. (2017) Regulatory T Cells in Multiple Sclerosis and Myasthenia Gravis. Journal of Neuroinflammation, 14, Article No. 117. https://doi.org/10.1186/s12974-017-0892-8
|
[30]
|
Marek-Trzonkowska, N., Mysliwiec, M., Dobyszuk, A., et al. (2014) Therapy of Type 1 Diabetes with CD4(+)CD25(High)CD127-Regulatory T Cells Prolongs Survival of Pancreatic Islets-Results of One Year Follow-Up. Clinical Immunology, 153, 23-30. https://doi.org/10.1016/j.clim.2014.03.016
|
[31]
|
Bluestone, J.A., Buckner, J.H., Fitch, M., et al. (2015) Type 1 Diabetes Immunotherapy Using Polyclonal Regulatory T Cells. Science Translational Medicine, 7, 315ra189. https://doi.org/10.1126/scitranslmed.aad4134
|
[32]
|
Mathew, J.M., Lefever, A., et al. (2018) A Phase I Clinical Trial with ex Vivo Expanded Recipient Regulatory T Cells in Living Donor Kidney Transplants. Scientific Reports, 8, Article No. 7428.
https://doi.org/10.1038/s41598-018-25574-7
|
[33]
|
Nikolouli, E., Hardtke-Wolenski, M., Hapke, M., et al. (2017) Alloantigen-Induced Regulatory T Cells Generated in Presence of Vitamin C Display Enhanced Stability of Foxp3 Ex-pression and Promote Skin Allograft Acceptance. Frontiers in Immunology, 8, Article No. 748. https://doi.org/10.3389/fimmu.2017.00748
|
[34]
|
Saadoun, D., et al. (2011) Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis. The New England Journal of Medicine, 365, 2067-2077. https://doi.org/10.1056/NEJMoa1105143
|
[35]
|
Koreth, J., Matsuoka, K., Kim, H.T., et al. (2011) Interleukin-2 and Regulatory T Cells in Graft-Versus-Host Disease. New England Journal of Medicine, 365, 2055-2066. https://doi.org/10.1056/NEJMoa1108188
|
[36]
|
Brunstein, C.G., Miller, J.S., Mckenna, D.H., et al. (2016) Umbil-ical Cord Blood-Derived T Regulatory Cells to Prevent GVHD: Kinetics, Toxicity Profile, and Clinical Effect. Blood, 127, 1044-1051.
https://doi.org/10.1182/blood-2015-06-653667
|
[37]
|
Rosenzwajg, M., Lorenzon, R., Cacoub, P., et al. (2019) Immunological and Clinical Effects of Low-Dose Interleukin-2 across 11 Autoimmune Diseases in a Single, Open Clinical Trial. Annals of the Rheumatic Diseases, 78, 209-217.
https://doi.org/10.1136/annrheumdis-2018-214229
|
[38]
|
Castela, E., Le Duff, F., Butori, C., et al. (2014) Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata. JAMA Dermatology, 150, 748-751.
https://doi.org/10.1001/jamadermatol.2014.504
|
[39]
|
Humrich, J.Y. and Riemekasten, G. (2016) Clinical Trials: The Rise of IL-2 Therapy—A Novel Biologic Treatment for SLE. Nature Reviews Rheumatology, 12, 695-696. https://doi.org/10.1038/nrrheum.2016.173
|
[40]
|
Rosenzwajg, M., Churlaud, G., Mallone, R., et al. (2015) Low-Dose Interleukin-2 Fosters a Dose-Dependent Regulatory T Cell Tuned Milieu in T1D Patients. Journal of Auto-immunity, 58, 48-58.
https://doi.org/10.1016/j.jaut.2015.01.001
|
[41]
|
Hartemann, A., Bensimon, G., Payan, C.A., et al. (2013) Low-Dose Interleukin 2 in Patients with Type 1 Diabetes: A Phase 1/2 Randomised, Double-Blind, Placebo-Controlled Trial. The Lancet Diabetes & Endocrinology, 1, 295-305.
https://doi.org/10.1016/S2213-8587(13)70113-X
|